157 related articles for article (PubMed ID: 34303837)
21. Diagnostic criteria and classification of mastocytosis in 2014.
Akin C; Valent P
Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670
[TBL] [Abstract][Full Text] [Related]
22. How to interpret mast cell tests.
Waterfield T; Dyer E; Wilson K; Boyle RJ
Arch Dis Child Educ Pract Ed; 2016 Oct; 101(5):246-51. PubMed ID: 27325614
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology, prognosis, and risk factors in mastocytosis.
Brockow K
Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674
[TBL] [Abstract][Full Text] [Related]
24. First Identification of an Inherited TPSAB1 Quintuplication in a Patient with Clonal Mast Cell Disease.
Sabato V; Chovanec J; Faber M; Milner JD; Ebo D; Lyons JJ
J Clin Immunol; 2018 May; 38(4):457-459. PubMed ID: 29748908
[No Abstract] [Full Text] [Related]
25. Association of Postural Tachycardia Syndrome and Ehlers-Danlos Syndrome with Mast Cell Activation Disorders.
Bonamichi-Santos R; Yoshimi-Kanamori K; Giavina-Bianchi P; Aun MV
Immunol Allergy Clin North Am; 2018 Aug; 38(3):497-504. PubMed ID: 30007466
[TBL] [Abstract][Full Text] [Related]
26. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
[TBL] [Abstract][Full Text] [Related]
27. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.
Valent P; Akin C; Arock M; Brockow K; Butterfield JH; Carter MC; Castells M; Escribano L; Hartmann K; Lieberman P; Nedoszytko B; Orfao A; Schwartz LB; Sotlar K; Sperr WR; Triggiani M; Valenta R; Horny HP; Metcalfe DD
Int Arch Allergy Immunol; 2012; 157(3):215-25. PubMed ID: 22041891
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
29. Mastocytosis: Moving the Field to Precision and Personalized Medicine.
Castells MC
Immunol Allergy Clin North Am; 2018 Aug; 38(3):xv-xvii. PubMed ID: 30007470
[No Abstract] [Full Text] [Related]
30. Syncope as a manifestation of mast cell activation disorder.
Perales Chordá C; Fabregat Nebot S; Moral Moral P; Jarque Ramos I; Hernández Fernandez de Rojas D
Ann Allergy Asthma Immunol; 2015 Feb; 114(2):153-4. PubMed ID: 25624133
[No Abstract] [Full Text] [Related]
31. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
32. INTERACTIVE MEDICAL CASE. A Stinging Sensation.
Lee-Sarwar K; Vaidya A; Shi M; Akin C
N Engl J Med; 2015 Jun; 372(26):e35. PubMed ID: 26107069
[No Abstract] [Full Text] [Related]
33. Mast cell disorders and idiopathic anaphylaxis: Evaluation and management.
Khalid MB; Lieberman P
Allergy Asthma Proc; 2020 Mar; 41(2):90-98. PubMed ID: 32122445
[No Abstract] [Full Text] [Related]
34. Systemic mastocytosis presenting as intraoperative anaphylaxis with atypical features: a report of two cases.
Bridgman DE; Clarke R; Sadleir PH; Stedmon JJ; Platt P
Anaesth Intensive Care; 2013 Jan; 41(1):116-21. PubMed ID: 23362901
[TBL] [Abstract][Full Text] [Related]
35. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
Ravi A; Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress markers are increased in patients with mastocytosis.
Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
[TBL] [Abstract][Full Text] [Related]
37. Mast cell mediators in allergic inflammation and mastocytosis.
Castells M
Immunol Allergy Clin North Am; 2006 Aug; 26(3):465-85. PubMed ID: 16931289
[TBL] [Abstract][Full Text] [Related]
38. Generalized pruritus relieved by NSAIDs in the setting of mast cell activation syndrome.
Kesterson K; Nahmias Z; Brestoff JR; Bodet ND; Kau A; Kim BS
J Allergy Clin Immunol Pract; 2018; 6(6):2130-2131. PubMed ID: 29577987
[No Abstract] [Full Text] [Related]
39. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
Azaña JM; Torrelo A; Matito A
Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
[TBL] [Abstract][Full Text] [Related]
40. Pseudoanaphylaxis.
Russell WJ; Smith WB
Anaesth Intensive Care; 2006 Dec; 34(6):801-3. PubMed ID: 17183902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
